Scrip: industry news and insights
China Roundup: Rare Disease Approvals, Local mRNA Shots, CEO Visits
By Brian Yang 05 Jun 2023
AstraZeneca and CANbridge obtain new approvals for their rare disease drugs in China, where a new domestic mRNA vaccine is...